{"id":23587,"date":"2025-04-13T17:40:01","date_gmt":"2025-04-13T17:40:01","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=23587"},"modified":"2025-10-03T07:27:28","modified_gmt":"2025-10-03T07:27:28","slug":"2-3-fea-40-mg-120-mg-pelet","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/tr\/urun\/2-3-fea-40-mg-120-mg-pelet\/","title":{"rendered":"2\/3-FEA 40 MG\/120MG Peletler"},"content":{"rendered":"

2\/3-FEA 40 MG \/ 120 MG Peletler \u2013 Bilimsel \u00dcr\u00fcn A\u00e7\u0131klamas\u0131<\/span><\/span><\/strong><\/h3>\n

Genel bilgi<\/span><\/span><\/strong><\/h4>\n

2\/3-FEA (2-Floroetamfetamin\/3-Floroetamfetamin)<\/span><\/span><\/strong> \u00a0bir\u00a0 <\/span><\/span>floroamfetamin t\u00fcrevi ailesinden bir ara\u015ft\u0131rma bile\u015fi\u011fi<\/span><\/span><\/strong> , potansiyel uyar\u0131c\u0131 ve empatik \u00f6zelliklere sahip. Bu peletler \u015funlar\u0131 i\u00e7erir:\u00a0 <\/span><\/span>40 mg 2-FEA ve 120 mg 3-FEA'n\u0131n hassas dozlanm\u0131\u015f kombinasyonu<\/span><\/span><\/strong> , i\u00e7in optimize edildi\u00a0 <\/span><\/span>klinik \u00f6ncesi \u00e7al\u0131\u015fmalar<\/span><\/span><\/strong> \u00a0veya farmakodinamik etkile\u015fimler.<\/span><\/span><\/p>\n

\n

Uygulamalar ve Ara\u015ft\u0131rma Alanlar\u0131<\/span><\/span><\/strong><\/h3>\n

Benzersiz ikili yap\u0131s\u0131 nedeniyle 2\/3-FEA \u015fu ama\u00e7larla incelenir:<\/span><\/span><\/p>\n

    \n
  1. \n

    N\u00f6rotransmitter ara\u015ft\u0131rmas\u0131<\/span><\/span><\/strong> \u00a0\u2013 Dopamin, norepinefrin ve serotonin sal\u0131n\u0131m\u0131 \u00fczerinde etkileri vard\u0131r.<\/span><\/span><\/p>\n<\/li>\n

  2. \n

    Davran\u0131\u015fsal farmakoloji<\/span><\/span><\/strong> \u00a0\u2013 Hayvan modellerinde hareket aktivitesi ve \u00f6d\u00fcl sistemleri \u00fczerindeki etkiler.<\/span><\/span><\/p>\n<\/li>\n

  3. \n

    Uyar\u0131c\u0131 Etkiler<\/span><\/span><\/strong> \u00a0\u2013 Klasik Amfetaminlerle Kar\u015f\u0131la\u015ft\u0131rmal\u0131 \u00c7al\u0131\u015fmalar.<\/span><\/span><\/p>\n<\/li>\n

  4. \n

    Resept\u00f6r afinitesi \u00e7al\u0131\u015fmalar\u0131<\/span><\/span><\/strong> \u00a0\u2013 Monoamin ta\u015f\u0131y\u0131c\u0131lar\u0131 i\u00e7in se\u00e7icili\u011fin ara\u015ft\u0131r\u0131lmas\u0131.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

    \u26a0\u00a0\u0130nsan kullan\u0131m\u0131 i\u00e7in de\u011fildir \u2013 Sadece in vitro ve kontroll\u00fc hayvan testleri i\u00e7indir.<\/span><\/span><\/strong><\/p>\n

    \n

    Dozaj ve Uygulama<\/span><\/span><\/strong><\/h3>\n

    Klinik \u00d6ncesi K\u0131lavuzlar:<\/span><\/span><\/strong><\/h4>\n
      \n
    • \n

      D\u00fc\u015f\u00fck Aktif Menzil:<\/span><\/span><\/strong> \u00a00,5-2 mg\/kg (hafif etkiler i\u00e7in)<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Orta Menzil:<\/span><\/span><\/strong> \u00a02-5 mg\/kg (net davran\u0131\u015fsal etkiler)<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Y\u00fcksek Aral\u0131k:<\/span><\/span><\/strong> \u00a05-10 mg\/kg (sadece akut toksisite \u00e7al\u0131\u015fmalar\u0131 i\u00e7in)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

      \u00c7\u00f6z\u00fcn\u00fcrl\u00fck:<\/span><\/span><\/strong><\/h4>\n
        \n
      • \n

        Serbest\u00e7e \u00e7\u00f6z\u00fcn\u00fcr\u00a0 <\/span><\/span>fizyolojik tuzlu su<\/span><\/span><\/strong> \u00a0(enjeksiyon i\u00e7in)<\/span><\/span><\/p>\n<\/li>\n

      • \n

        Az miktarda \u00e7\u00f6z\u00fcn\u00fcr\u00a0 <\/span><\/span>DMSO<\/span><\/span><\/strong> \u00a0(in vitro \u00e7al\u0131\u015fma i\u00e7in)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

        Uygulama yollar\u0131:<\/span><\/span><\/strong><\/h4>\n
          \n
        • \n

          Oral (hayvan modelleri)<\/span><\/span><\/p>\n<\/li>\n

        • \n

          \u0130ntraperitoneal (daha h\u0131zl\u0131 emilim i\u00e7in)<\/span><\/span><\/p>\n<\/li>\n

        • \n

          In vitro ta\u015f\u0131y\u0131c\u0131 analizleri<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

          \n

          G\u00fcvenlik Y\u00f6nleri ve Riskler<\/span><\/span><\/strong><\/h3>\n

          Akut Riskler:<\/span><\/span><\/strong><\/h4>\n
            \n
          • \n

            Kardiyovask\u00fcler stres<\/span><\/span><\/strong> \u00a0(kalp at\u0131\u015f h\u0131z\u0131n\u0131n\/kan bas\u0131nc\u0131n\u0131n artmas\u0131)<\/span><\/span><\/p>\n<\/li>\n

          • \n

            \u00a0Y\u00fcksek doz <\/span>hipertermi<\/span><\/strong><\/span><\/p>\n<\/li>\n

          • \n

            Serotonin sendromu<\/span><\/span><\/strong> \u00a0MAO inhibit\u00f6rleri ile birle\u015ftirildi\u011finde<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

            Kronik Riskler:<\/span><\/span><\/strong><\/h4>\n
              \n
            • \n

              N\u00f6rotoksisite<\/span><\/span><\/strong> \u00a0(uzun s\u00fcreli y\u00fcksek dozlarda)<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Dopaminerjik t\u00fckenme<\/span><\/span><\/strong><\/p>\n<\/li>\n

            • \n

              Davran\u0131\u015fsal duyarl\u0131l\u0131k<\/span><\/span><\/strong><\/p>\n<\/li>\n<\/ul>\n

              \n

              Laboratuvar analizi ve kalite kontrol\u00fc<\/span><\/span><\/strong><\/h3>\n

              Analitik \u00d6zellikler:<\/span><\/span><\/strong><\/h4>\n
                \n
              • \n

                HPLC-MS onay\u0131<\/span><\/span><\/strong> \u00a0kompozisyonun<\/span><\/span><\/p>\n<\/li>\n

              • \n

                Oran 1:3 (2-FEA:3-FEA)<\/span><\/span><\/strong> \u00a0<5% varyans\u0131 ile<\/span><\/span><\/p>\n<\/li>\n

              • \n

                Tespit edilebilir izomerik safs\u0131zl\u0131k yok<\/span><\/span><\/strong><\/p>\n<\/li>\n

              • \n

                Mikrobiyolojik safl\u0131k:<\/span><\/span><\/strong> \u00a0<100 CFU\/g<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                Stabilite verileri:<\/span><\/span><\/strong><\/h4>\n
                  \n
                • \n

                  Raf \u00f6mr\u00fc:<\/span><\/span><\/strong> \u00a04\u00b0C'de 24 ay<\/span><\/span><\/p>\n<\/li>\n

                • \n

                  Fotosensitivite:<\/span><\/span><\/strong> \u00a0Kehribar ambalaj\u0131nda saklay\u0131n<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                  \n

                  \u00d6nerilen Ara\u015ft\u0131rma Protokolleri<\/span><\/span><\/strong><\/h3>\n
                    \n
                  1. \n

                    Mikrodiyaliz \u00c7al\u0131\u015fmalar\u0131<\/span><\/span><\/strong><\/p>\n

                      \n
                    • \n

                      Nucleus accumbens'te ekstrasel\u00fcler dopaminin ger\u00e7ek zamanl\u0131 izlenmesi<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

                    • \n

                      Ko\u015fullu Yer Tercihi<\/span><\/span><\/strong><\/p>\n

                        \n
                      • \n

                        \u00d6d\u00fcl potansiyeli de\u011ferlendirmesi<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

                      • \n

                        Termoreg\u00fclasyon \u00c7al\u0131\u015fmalar\u0131<\/span><\/span><\/strong><\/p>\n

                          \n
                        • \n

                          V\u00fccut \u0131s\u0131s\u0131 \u00fczerindeki etkiler<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

                        • \n

                          Elektrofizyoloji<\/span><\/span><\/strong><\/p>\n

                            \n
                          • \n

                            Dopamin n\u00f6ronlar\u0131n\u0131n ate\u015fleme \u00f6r\u00fcnt\u00fc analizi<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n

                            \n

                            S\u0131k\u00e7a Sorulan Sorular<\/span><\/span><\/strong><\/h3>\n

                            S1: 2-FEA ile 3-FEA aras\u0131ndaki temel fark nedir?<\/span><\/span><\/strong>
                            \n A: 2-FEA daha b\u00fcy\u00fck bir performans sergiliyor\u00a0 <\/span><\/span>dopaminerjik se\u00e7icilik<\/span><\/span><\/strong> , 3-FEA ise daha g\u00fc\u00e7l\u00fc\u00a0 <\/span><\/span>serotoninerjik etkiler<\/span><\/span><\/strong> \u00a0.<\/span><\/span><\/p>\n

                            S2: Bu kombinasyon 3-FMA ile nas\u0131l kar\u015f\u0131la\u015ft\u0131r\u0131l\u0131r?<\/span><\/span><\/strong>
                            \n A: 2\/3-FEA kombinasyonunun bir\u00a0 <\/span><\/span>daha hafif etki profili<\/span><\/span><\/strong> \u00a0daha d\u00fc\u015f\u00fck n\u00f6rotoksisite potansiyeline sahiptir.<\/span><\/span><\/p>\n

                            S3: \u0130zomer olu\u015fumu riski var m\u0131d\u0131r?<\/span><\/span><\/strong>
                            \n A: Analitik verilerimiz \u015funu g\u00f6steriyor:\u00a0 <\/span><\/span>istenmeyen izomer yok<\/span><\/span><\/strong> \u00a0Do\u011fru \u015fekilde sakland\u0131\u011f\u0131nda olu\u015fur.<\/span><\/span><\/p>\n

                            \n

                            Yasal Not:<\/span><\/span><\/strong>
                            \n Bu \u00fcr\u00fcn a\u015fa\u011f\u0131daki kategorilere giriyor:\u00a0 <\/span><\/span>Afyon Yasas\u0131<\/span><\/span><\/strong> \u00a0Hollanda'da ve\u00a0 <\/span><\/span>yaln\u0131zca yasal bilimsel ara\u015ft\u0131rma i\u00e7in tasarlanm\u0131\u015ft\u0131r<\/span><\/span><\/strong> \u00a0Gerekli izinler al\u0131nm\u0131\u015f olarak.<\/span><\/span><\/p>\n

                            Saklama ko\u015fullar\u0131:<\/span><\/span><\/strong><\/p>\n

                              \n
                            • \n

                              S\u0131cakl\u0131k: 2-8\u00b0C<\/span><\/span><\/p>\n<\/li>\n

                            • \n

                              Nem ve \u0131\u015f\u0131ktan korunmu\u015ftur<\/span><\/span><\/p>\n<\/li>\n

                            • \n

                              G\u0131dalardan uzakta saklay\u0131n<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                              ","protected":false},"excerpt":{"rendered":"

                              Newphoria 2\/3-FEA Peletleri ile de\u011fi\u015ftirildi >><\/span><\/span><\/span><\/span><\/strong><\/span><\/p>","protected":false},"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[322,333,324],"product_tag":[326],"class_list":{"0":"post-23587","1":"product","2":"type-product","3":"status-publish","5":"product_cat-bijna-verboden","6":"product_cat-gefluoreerden","7":"product_cat-pellets-for-pellet","8":"product_tag-nl","10":"first","11":"instock","12":"taxable","13":"shipping-taxable","14":"purchasable","15":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product\/23587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/comments?post=23587"}],"version-history":[{"count":5,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product\/23587\/revisions"}],"predecessor-version":[{"id":28068,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product\/23587\/revisions\/28068"}],"wp:attachment":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/media?parent=23587"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product_brand?post=23587"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product_cat?post=23587"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product_tag?post=23587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}